FDCDDQ
ABCL icon

Federation des caisses Desjardins du Quebec’s AbCellera Biologics ABCL Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$136K Sell
39,030
-832
-2% -$2.99K ﹤0.01% 1615
2025
Q4 		$136K Sell
39,862
-3,794
-9% -$16.9K ﹤0.01% 1593
2025
Q3 		$219K Buy
43,656
+26,356
+152% +$116K ﹤0.01% 1454
2025
Q2 		$59.3K Buy
17,300
+2,000
+13% +$4.98K ﹤0.01% 1507
2025
Q1 		$34.1K Sell
15,300
-100
-0.6% -$287 ﹤0.01% 1560
2024
Q4 		$45.1K Buy
15,400
+3,650
+31% +$10.2K ﹤0.01% 1446
2024
Q3 		$30.6K Buy
11,750
+1,550
+15% +$4.29K ﹤0.01% 1538
2024
Q2 		$30.2K Buy
10,200
+1,450
+17% +$5.49K ﹤0.01% 1502
2024
Q1 		$39.6K Buy
8,750
+750
+9% +$3.83K ﹤0.01% 1471
2023
Q4 		$45.7K Buy
8,000
+2,000
+33% +$9.27K ﹤0.01% 1341
2023
Q3 		$27.6K Buy
6,000
+500
+9% +$3.04K ﹤0.01% 1483
2023
Q2 		$35.5K Hold
5,500
– – ﹤0.01% 1428
2023
Q1 		$41.5K Hold
5,500
– – ﹤0.01% 1385
2022
Q4 		$55.7K Sell
5,500
-1,000
-15% -$11.6K ﹤0.01% 1419
2022
Q3 		$64.3K Buy
6,500
+200
+3% +$2.19K ﹤0.01% 1446
2022
Q2 		$67.1K Buy
6,300
+800
+15% +$6.77K ﹤0.01% 1452
2022
Q1 		$53.6K Buy
5,500
+1,475
+37% +$14K ﹤0.01% 1567
2021
Q4 		$57.6K Sell
4,025
-750
-16% -$11.4K ﹤0.01% 1556
2021
Q3 		$95.7K Buy
4,775
+2,350
+97% +$41.5K ﹤0.01% 1419
2021
Q2 		$53.4K Buy
+2,425
New +$66.9K ﹤0.01% 1593

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ABCL Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec reduced its AbCellera Biologics (ABCL) stake by 2.1% in Q1 2026, selling an estimated $2.99K and leaving 39,030 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #1615.

Federation des caisses Desjardins du Quebec first reported a position in ABCL in Q2 2021 and has held it in 20 quarters since. The position peaked at $219K in Q3 2025. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 39,030 shares of AbCellera Biologics worth $136K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec sold 832 AbCellera Biologics shares in Q1 2026, an estimated $2.99K.
  • AbCellera Biologics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1615 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in AbCellera Biologics in Q2 2021 and has held it in 20 quarters since.
  • Federation des caisses Desjardins du Quebec's AbCellera Biologics position peaked at $219K in Q3 2025.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.